https://www.selleckchem.com/pr....oducts/elacridar-gf1
Integrative oncology (IO) is increasingly becoming part of palliative cancer care. This study examined the correlation between an IO treatment program and rates of survival among patients with advanced gynecological cancer. Patients were referred by their oncology healthcare professionals to an integrative physician (IP) for consultation and IO treatments. Those undergoing at least 4 treatments during the 6weeks following the consultation were considered adherence to the integrative care program (AIC), versus non-adherent (no
Like
Comment
Share
